Advertisement

Topics

Complement Genomics Company Profile

17:22 EDT 20th June 2018 | BioPortfolio

We also provide a walk-in service for the North of England which includes Northumberland, Tyne & Wear, County Durham, Teeside, Yorkshire and Cumbria. Our laboratories are easily
accessible and are located in Sunderland which is not too far away from all the local major
areas including Durham, Newcastle, Middlesbrough, Hartlepool, Leeds, York, Harrogate,
Carlisle, Darlington, Doncaster and Hexham.

Contact

Phone: 44 (0)191 5166500
Email: sales@dadcheck.com


News Articles [319 Associated News Articles listed on BioPortfolio]

Alexion, Complement co-develop CP010 for neurodegenerative disorders; Alexion has option to acquire company

Alexion Pharmaceuticals Inc. and Complement Pharma are collaborating on the development of Complement's CP010 for neurodegenerative disorders.

Alexion, Complement to develop neurodegenerative disease candidate

Alexion signed a deal with Complement Pharma that aims to develop the latter's preclinical complement 6 inhibitor CP010 under -More- 

Alexion and Complement Pharma Partner to Develop Complement Inhibitor for Neurodegenerative Disorders

NEW HAVEN, Conn., & AMSTERDAM–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Complement Pharma today announced a partnership to co-develop the preclinical C6 complemen...

Berry Genomics Collaborates with 10X Genomics for Next-Gen Prenatal Tests

Berry Genomics of Beijing will collaborate with California's 10X Genomics to develop next-gen noninvasive prenatal tests (NIPT). Specifically, the companies will incorporate 10X's haplotype genomic in...

Genomics England announces appointment of global genomics pioneer as first CEO

Genomics England announces the appointment of its first Chief Executive Officer (CEO) today. Global genomics pioneer Professor John Mattick will join Genomics England in June. He will lead the organiz...

Rosetta Genomics Ltd.: Genoptix Completes Acquisition of PersonalizeDx from Rosetta Genomics

-First step in the process of Genoptix acquiring all of Rosetta Genomics -Next step is the completion of a merger for $8 million in cash pursuant to which value to Rosetta Genomics' equity holders...

Alexion goes back to roots with Complement deal

Alexion has made a lot of money from investing in the science behind complement inhibitors – C5 inhibitor, Soliris, has been a huge earner for the company. Now, the company has decided to return to ...

Nebula wants to democratise genome sequencing, with the help of blockchain and cryptocurrency

A new start-up has been launched with a dazzling, technology-enabled vision of putting genomics into the hands of the DNA’s owners – individuals – rather than what it calls genomics ‘middle me...

Drugs and Medications [0 Results]

None

PubMed Articles [283 Associated PubMed Articles listed on BioPortfolio]

Genomics Education: Knowledge of Nurses Across the Profession and Integration Into Practice.

Since the completion of the Human Genome Project in 2003, the implications of genetics and genomics for health and illness have become clearer. All nurses, at all levels and across all specialties, mu...

Binding of human complement C1 sterase inhibitor to Leptospira spp.

Leptospirosis is an important zoonosis of global importance caused by bacteria Leptospira spp. Pathogenic Leptospira is resistant to Complement System killing while non-pathogenic Leptospira is rapidl...

Bacterial Autophagy: How to Take a Complement.

Complement, a complex system of serum proteins, contributes to host defense through multiple mechanisms. In this issue of Cell Host & Microbe, Sorbara et al. (2018) discovered that cytosolic pathogen...

Recent developments of software and database in microbial genomics and functional genomics.

Genetics and Genomics: An Oncology Nurse's Journey in Practice.

Cancer genetics and genomics are now an integral component of oncology care. Genetics and genomics guide recommendations not only for cancer prevention and early detection, but also for cancer treatme...

Clinical Trials [114 Associated Clinical Trials listed on BioPortfolio]

First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers

Safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of a Single Ascending Dose (SAD) and a Multiple Dose (MD) of the complement inhibitor AMY-101. A prospective, single-c...

Complement Diagnosis of Acute Appendicitis

Acute appendicitis is a common condition requiring urgent surgery but is often difficult to distinguish from other non-surgical conditions such as urinary infections, pelvic inflammatory d...

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Procedure Outcome Predictor (POP) Using the Complement Cascade

Current post-operative monitoring of patient recovery consists measuring two blood markers C-reactive protein (CRP) and White Blood Cell Count (WBC). However, these are slow to respond to ...

Companies [414 Associated Companies listed on BioPortfolio]

Complement Genomics

We also provide a walk-in service for the North of England which includes Northumberland, Tyne & Wear, County Durham, Teeside, Yorkshire and Cumbria. Our laboratories are easily accessible and are loc...

True North Therapeutics, Inc.

True North Therapeutics is a biotechnology company developing novel therapies that selectively target the Complement pathway of the immune system to address fundamental mechanisms...

True North Therapeutics

True North Therapeutics is a biotechnology company developing novel therapies that selectively target the Complement pathway of the immune system to address fundamental mechanisms...

Genomics in Business

In 2003 Keygene initiated the first edition of Genomics in Business. It was the first conference to focus on the existing and future applications of genomics in the Agro-Food industry. With participan...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

More Information about "Complement Genomics" on BioPortfolio

We have published hundreds of Complement Genomics news stories on BioPortfolio along with dozens of Complement Genomics Clinical Trials and PubMed Articles about Complement Genomics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Complement Genomics Companies in our database. You can also find out about relevant Complement Genomics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record